SUBJECTS : Oncology | Tumour Biology | Cancer Antigen
Molecular Cancer: 2023, vol: 22, issue: 1
- 1)- Kavita R Gajbhiye, Rajesh Salve, Mahavir Narwade, Afsana Sheikh, Prashant Kesharwani, Virendra Gajbhiye. Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics. Molecular cancer. 2023, 22 (1): 160
Cited : 11Read More - 2)- Einar Birkeland, Giulio Ferrero, Barbara Pardini, Sinan U Umu, Sonia Tarallo, Sara Bulfamante, Geir Hoff, Carlo Senore, Trine B Rounge, Alessio Naccarati. Profiling small RNAs in fecal immunochemical tests: is it possible? Molecular cancer. 2023, 22 (1): 161Cited : 2Read More
- 3)- Sandy Figiel, Wencheng Yin, Dimitrios Doultsinos, Andrew Erickson, Ninu Poulose, Reema Singh, Anette Magnussen, Thineskrishna Anbarasan, Renuka Teague, Mengxiao He, Joakim Lundeberg, Massimo Loda, Clare Verrill, Richard Colling, Pelvender S Gill, Richard J Bryant, Freddie C Hamdy, Dan J Woodcock, Ian G Mills, Olivier Cussenot, Alastair D Lamb. Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures. Molecular cancer. 2023, 22 (1): 162Cited : 2Read More
- 4)- Meijian Liao, Xiaolin Sun, Wendan Zheng, Mengdi Wu, Yifan Wang, Jia Yao, Yu Ma, Shoucui Gao, Dongsheng Pei. LINC00922 decoys SIRT3 to facilitate the metastasis of colorectal cancer through up-regulation the H3K27 crotonylation of ETS1 promoter. Molecular cancer. 2023, 22 (1): 163Cited : 3Read More
- 5)- Si-Cho Kim, Da-Won Kim, Eun Ju Cho, Jin-Young Lee, Jiwon Kim, Chaesun Kwon, Jeongsil Kim-Ha, Suk Kyun Hong, YoungRok Choi, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Won Kim, Woojin Kim, Hyunsoo Kim, Yoon Jun Kim, Jung-Hwan Yoon, Su Jong Yu, Young-Joon Kim. A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma. Molecular cancer. 2023, 22 (1): 164Cited : 5Read More
- 6)- Ameya Champhekar, Rachel Heymans, Justin Saco, Guillem Turon Font, Cynthia Gonzalez, Anne Gao, John Pham, June Lee, Ryan Maryoung, Egmidio Medina, Katie M Campbell, Daniel Karin, David Austin, Robert Damioseaux, Antoni Ribas. ERK mediates interferon gamma-induced melanoma cell death. Molecular cancer. 2023, 22 (1): 165Cited : 5Read More
- 7)- Yi Zhang, Min Kang, Bin Zhang, Fanchao Meng, Jun Song, Hiroshi Kaneko, Fumio Shimamoto, Bo Tang. Retraction Note: mA modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5. Molecular cancer. 2023, 22 (1): 166Cited : 0Read More
- 8)- Kangchun Wang, Xin Wang, Qi Pan, Bei Zhao. Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation. Molecular cancer. 2023, 22 (1): 167Cited : 10Read More
- 9)- Nazeer Hasan, Arif Nadaf, Mohammad Imran, Umme Jiba, Afsana Sheikh, Waleed H Almalki, Salem Salman Almujri, Yousuf Hussain Mohammed, Prashant Kesharwani, Farhan Jalees Ahmad. Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches. Molecular cancer. 2023, 22 (1): 168Cited : 21Read More
- 10)- Mohammad Chehelgerdi, Matin Chehelgerdi, Omer Qutaiba B Allela, Renzon Daniel Cosme Pecho, Narayanan Jayasankar, Devendra Pratap Rao, Tamilanban Thamaraikani, Manimaran Vasanthan, Patrik Viktor, Natrayan Lakshmaiya, Mohamed J Saadh, Ayesha Amajd, Mabrouk A Abo-Zaid, Roxana Yolanda Castillo-Acobo, Ahmed H Ismail, Ali H Amin, Reza Akhavan-Sigari. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Molecular cancer. 2023, 22 (1): 169Cited : 88Read More
- 11)- Chenxi Ma, Chengzhe Yang, Ai Peng, Tianyong Sun, Xiaoli Ji, Jun Mi, Li Wei, Song Shen, Qiang Feng. Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. Molecular cancer. 2023, 22 (1): 170Cited : 22Read More
- 12)- Yansui Mai, Jiyan Su, Chuan Yang, Chenglai Xia, Liwu Fu. The strategies to cure cancer patients by eradicating cancer stem-like cells. Molecular cancer. 2023, 22 (1): 171Cited : 9Read More
- 13)- Zhen Zeng, Minyang Fu, Yuan Hu, Yuquan Wei, Xiawei Wei, Min Luo. Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer. Molecular cancer. 2023, 22 (1): 172Cited : 15Read More
- 14)- Tao Xie, Du-Jiang Fu, Zhi-Min Li, Dao-Jun Lv, Xian-Lu Song, Yu-Zhong Yu, Chong Wang, Kang-Jin Li, Baoqian Zhai, Jiacheng Wu, Ning-Han Feng, Shan-Chao Zhao. Correction: CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling. Molecular cancer. 2023, 22 (1): 173Cited : 0Read More
- 15)- Liangliang Xu, Peng Wang, Li Li, Lian Li, Yang Huang, Yanfang Zhang, Xiaobo Zheng, Pengsheng Yi, Ming Zhang, Mingqing Xu. circPSD3 is a promising inhibitor of uPA system to inhibit vascular invasion and metastasis in hepatocellular carcinoma. Molecular cancer. 2023, 22 (1): 174Cited : 3Read More
- 16)- Martina S J McDermott, Brigid C Browne, Neil T Conlon, Neil A O'Brien, Dennis J Slamon, Michael Henry, Paula Meleady, Martin Clynes, Paul Dowling, John Crown, Norma O'Donovan. Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy. Molecular cancer. 2023, 22 (1): 175Cited : 0Read More
- 17)- Arnaud Bayle, Laila Belcaid, Lola-Jade Palmieri, Diego Teysonneau, Sophie Cousin, Mariella Spalato-Ceruso, Mihaela Aldea, Damien Vasseur, Melissa Alame, Laura Blouin, Isabelle Soubeyran, Claudio Nicotra, Maud Ngocamus, Antoine Hollebecque, Yohann Loriot, Benjamin Besse, Ludovic Lacroix, Etienne Rouleau, Fabrice Barlesi, Fabrice Andre, Antoine Italiano. Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study. Molecular cancer. 2023, 22 (1): 176Cited : 1Read More
- 18)- Ji Eun Shin, Soo-Hyun Kim, Mingyu Kong, Hwa-Ryeon Kim, Sungmin Yoon, Kyung-Mi Kee, Jung Ah Kim, Dong Hyeon Kim, So Yeon Park, Jae Hyung Park, Hongtae Kim, Kyoung Tai No, Han-Woong Lee, Heon Yung Gee, Seunghee Hong, Kun-Liang Guan, Jae-Seok Roe, Hyunbeom Lee, Dong-Wook Kim, Hyun Woo Park. Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia. Molecular cancer. 2023, 22 (1): 177Cited : 2Read More
- 19)- Cyril Roussel-Simonin, Felix Blanc-Durand, Roseline Tang, Damien Vasseur, Audrey Le Formal, Laure Chardin, Elisa Yaniz, Sébastien Gouy, Amandine Maulard, Stéphanie Scherier, Claire Sanson, Ludovic Lacroix, Sophie Cotteret, Lea Mauny, François Zaccarini, Etienne Rouleau, Alexandra Leary. Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid. Molecular cancer. 2023, 22 (1): 178Cited : 0Read More
- 20)- Yumeng Cui, Xiaojie Wu, Jie Jin, Weiling Man, Jie Li, Xiang Li, Yanghua Li, He Yao, Rongbin Zhong, Shiyun Chen, Jiahui Wu, Tianhao Zhu, Yanli Lin, Junjie Xu, Youliang Wang. CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis. Molecular cancer. 2023, 22 (1): 179Cited : 9Read More
- 21)- Tatjana Sauerer, Giuliano Filippini Velázquez, Christoph Schmid. Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy. Molecular cancer. 2023, 22 (1): 180Cited : 9Read More
- 22)- Nikolas H Stoecklein, Georg Fluegen, Rosa Guglielmi, Rui P L Neves, Thilo Hackert, Emrullah Birgin, Stefan A Cieslik, Monica Sudarsanam, Christiane Driemel, Guus van Dalum, André Franken, Dieter Niederacher, Hans Neubauer, Tanja Fehm, Jutta M Rox, Petra Böhme, Lena Häberle, Wolfgang Göring, Irene Esposito, Stefan A Topp, Frank A W Coumans, Jürgen Weitz, Wolfram T Knoefel, Johannes C Fischer, Ulrich Bork, Nuh N Rahbari. Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis. Molecular cancer. 2023, 22 (1): 181Cited : 3Read More
- 23)- Dijana Djureinovic, Sarah A Weiss, Irina Krykbaeva, Rihao Qu, Ioannis Vathiotis, Myrto Moutafi, Lin Zhang, Ana L Perdigoto, Wei Wei, Gail Anderson, William Damsky, Michael Hurwitz, Barbara Johnson, David Schoenfeld, Amit Mahajan, Frank Hsu, Kathryn Miller-Jensen, Yuval Kluger, Mario Sznol, Susan M Kaech, Marcus Bosenberg, Lucia B Jilaveanu, Harriet M Kluger. A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better. Molecular cancer. 2023, 22 (1): 182Cited : 1Read More
- 24)- Faezeh Ramezani, Ahmad Reza Panahi Meymandi, Behnia Akbari, Omid Reza Tamtaji, Hamed Mirzaei, Christine E Brown, Hamid Reza Mirzaei. Outsmarting trogocytosis to boost CAR NK/T cell therapy. Molecular cancer. 2023, 22 (1): 183Cited : 3Read More
- 25)- Tushuai Li, Longjiang Xu, Zhe Wei, Shaomei Zhang, Xingyu Liu, Yanzi Yang, Yue Gu, Jie Zhang. ELF5 drives angiogenesis suppression though stabilizing WDTC1 in renal cell carcinoma. Molecular cancer. 2023, 22 (1): 184Cited : 3Read More
- 26)- Kazumasa Komura, Kensuke Hirosuna, Satoshi Tokushige, Takuya Tsujino, Kazuki Nishimura, Mitsuaki Ishida, Takuo Hayashi, Ayako Ura, Takaya Ohno, Shogo Yamazaki, Keita Nakamori, Shoko Kinoshita, Ryoichi Maenosono, Masahiko Ajiro, Yuki Yoshikawa, Tomoaki Takai, Takeshi Tsutsumi, Kohei Taniguchi, Tomohito Tanaka, Kiyoshi Takahara, Tsuyoshi Konuma, Teruo Inamoto, Yoshinobu Hirose, Fumihito Ono, Yuichi Shiraishi, Akihide Yoshimi, Haruhito Azuma. The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer. Molecular cancer. 2023, 22 (1): 185Cited : 4Read More
- 27)- Kumar Nikhil, Kavita Shah. CDK5: an oncogene or an anti-oncogene: location location location. Molecular cancer. 2023, 22 (1): 186Cited : 0Read More
- 28)- Ming Yi, Tianye Li, Mengke Niu, Qi Mei, Bin Zhao, Qian Chu, Zhijun Dai, Kongming Wu. Exploiting innate immunity for cancer immunotherapy. Molecular cancer. 2023, 22 (1): 187Cited : 15Read More
- 29)- Weijing Sun, Natalie Streeter, Joseph McGuirk, Roy Jensen. The University of Kansas Cancer Center (KUCC), an NCI designated comprehensive cancer center. Molecular cancer. 2023, 22 (1): 188Cited : 0Read More
- 30)- Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, Hamidreza Kabiri, Hosein Salehian-Dehkordi, Mohammad Abdolvand, Sharareh Salmanizadeh, Mohsen Rashidi, Anoosha Niazmand, Saba Ahmadi, Sara Feizbakhshan, Saber Kabiri, Nasimeh Vatandoost, Tayebeh Ranjbarnejad. Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy. Molecular cancer. 2023, 22 (1): 189Cited : 10Read More
- 31)- Pere Llinàs-Arias, Miquel Ensenyat-Mendez, Sandra Íñiguez-Muñoz, Javier I J Orozco, Betsy Valdez, Matthew P Salomon, Chikako Matsuba, Maria Solivellas-Pieras, Andrés F Bedoya-López, Borja Sesé, Anja Mezger, Mattias Ormestad, Fernando Unzueta, Siri H Strand, Alexander D Boiko, E Shelley Hwang, Javier Cortés, Maggie L DiNome, Manel Esteller, Mathieu Lupien, Diego M Marzese. Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors. Molecular cancer. 2023, 22 (1): 190Cited : 2Read More
- 32)- Sandra Van Lint, Alexander Van Parys, Bram Van Den Eeckhout, Niels Vandamme, Stephane Plaisance, Annick Verhee, Dominiek Catteeuw, Elke Rogge, Jennifer De Geest, Nele Vanderroost, Jana Roels, Yvan Saeys, Gilles Uzé, Niko Kley, Anje Cauwels, Jan Tavernier. A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state. Molecular cancer. 2023, 22 (1): 191Cited : 2Read More
- 33)- Andrea Sacconi, Paola Muti, Claudio Pulito, Giulia Urbani, Matteo Allegretti, Raul Pellini, Nikolay Mehterov, Uri Ben-David, Sabrina Strano, Paolo Bossi, Giovanni Blandino. Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients. Molecular cancer. 2023, 22 (1): 192Cited : 1Read More
- 34)- Siyin Guo, Jing Huang, Genpeng Li, Wenjie Chen, Zhihui Li, Jianyong Lei. The role of extracellular vesicles in circulating tumor cell-mediated distant metastasis. Molecular cancer. 2023, 22 (1): 193Cited : 5Read More
- 35)- Xiangyu Wu, Tianhang Li, Rui Jiang, Xin Yang, Hongqian Guo, Rong Yang. Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects. Molecular cancer. 2023, 22 (1): 194Cited : 8Read More
- 36)- Lei Xu, Xiao Ma, Xiuzhong Zhang, Chong Zhang, Yi Zhang, Shuai Gong, Nai Wu, Peng Zhang, Xinyu Feng, Jiaxuan Guo, Mengmeng Zhao, Zeqiang Ren, Pengbo Zhang. hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and promote gemcitabine resistance in pancreatic ductal adenocarcinoma. Molecular cancer. 2023, 22 (1): 195Cited : 4Read More
- 37)- Nuria Tubío-Santamaría, Ashok Kumar Jayavelu, Tina M Schnoeder, Theresa Eifert, Chen-Jen Hsu, Florian Perner, Qirui Zhang, Daniela V Wenge, Fynn M Hansen, Joanna M Kirkpatrick, Nidhi Jyotsana, Steven W Lane, Björn von Eyss, Aniruddha J Deshpande, Michael W M Kühn, Juerg Schwaller, Clemens Cammann, Ulrike Seifert, Frédéric Ebstein, Elke Krüger, Andreas Hochhaus, Michael Heuser, Alessandro Ori, Matthias Mann, Scott A Armstrong, Florian H Heidel. Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia. Molecular cancer. 2023, 22 (1): 196Cited : 1Read More
- 38)- Tao Han, Lujun Chen, Kerui Li, Qilin Hu, Yue Zhang, Xuan You, Lei Han, Tingsong Chen, Kai Li. Significant CircRNAs in liver cancer stem cell exosomes: mediator of malignant propagation in liver cancer? Molecular cancer. 2023, 22 (1): 197Cited : 2Read More
- 39)- Mingyu Han, Haifeng Sun, Quanbo Zhou, Jinbo Liu, Junhong Hu, Weitang Yuan, Zhenqiang Sun. Effects of RNA methylation on Tumor angiogenesis and cancer progression. Molecular cancer. 2023, 22 (1): 198Cited : 2Read More
- 40)- Ya'nan Yang, Jieyun Zhang, Wen Zhang, Yixuan Wang, Yujia Zhai, Yan Li, Wenhua Li, Jinjia Chang, Xiaoying Zhao, Mingzhu Huang, Qirong Geng, Yue Yang, Zhe Gong, Nuoya Yu, Wei Shen, Qian Li, Shenglin Huang, Weijian Guo. A liquid biopsy signature of circulating extracellular vesicles-derived RNAs predicts response to first line chemotherapy in patients with metastatic colorectal cancer. Molecular cancer. 2023, 22 (1): 199Cited : 0Read More
- 41)- Yunlin Zhang, Ruchi P Patel, Ki Hyun Kim, Hyungwoo Cho, Jae-Cheol Jo, Seong Hyun Jeong, Sung Yong Oh, Yoon Seok Choi, Sung Hyun Kim, Ji Hyun Lee, Mathew Angelos, Puneeth Guruprasad, Ivan Cohen, Ositadimma Ugwuanyi, Yong Gu Lee, Raymone Pajarillo, Jong Hyun Cho, Alberto Carturan, Luca Paruzzo, Guido Ghilardi, Michael Wang, Soohwan Kim, Sung-Min Kim, Hyun-Jong Lee, Ji-Ho Park, Leiguang Cui, Tae Bum Lee, In-Sik Hwang, Young-Ha Lee, Yong-Jun Lee, Patrizia Porazzi, Dongfang Liu, Yoon Lee, Jong-Hoon K. Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study. Molecular cancer. 2023, 22 (1): 200Cited : 3Read More
- 42)- Manuela Giansanti, Tobias Theinert, Sarah Katharina Boeing, Dorothee Haas, Paul-Gerhardt Schlegel, Paola Vacca, Francesca Nazio, Ignazio Caruana. Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies. Molecular cancer. 2023, 22 (1): 201Cited : 1Read More
- 43)- Kaixuan Zeng, Jianhong Peng, Yue Xing, Linjie Zhang, Peishan Zeng, Weihao Li, Weili Zhang, Zhizhong Pan, Chi Zhou, Junzhong Lin. A positive feedback circuit driven by mA-modified circular RNA facilitates colorectal cancer liver metastasis. Molecular cancer. 2023, 22 (1): 202Cited : 2Read More
- 44)- Ming Yue, Shengyun Hu, Haifeng Sun, Baojing Tuo, Bin Jia, Chen Chen, Wenkang Wang, Jinbo Liu, Yang Liu, Zhenqiang Sun, Junhong Hu. Extracellular vesicles remodel tumor environment for cancer immunotherapy. Molecular cancer. 2023, 22 (1): 203Cited : 11Read More
- 45)- Juntae Kwon, Jinmin Zhang, Boram Mok, Samuel Allsup, Chul Kim, Jeffrey Toretsky, Cecil Han. USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity. Molecular cancer. 2023, 22 (1): 204Cited : 2Read More
- 46)- Zhenyan Miao, Jifei Li, Yu Wang, Mingqin Shi, Xiao Gu, Xuanqi Zhang, Fang Wei, Xinying Tang, Lufeng Zheng, Yingying Xing. Hsa_circ_0136666 stimulates gastric cancer progression and tumor immune escape by regulating the miR-375/PRKDC Axis and PD-L1 phosphorylation. Molecular cancer. 2023, 22 (1): 205Cited : 6Read More
- 47)- Muhammad Sufyan Bin Masroni, Kee Wah Lee, Victor Kwan Min Lee, Siok Bian Ng, Chao Teng Law, Kok Siong Poon, Bernett Teck-Kwong Lee, Zhehao Liu, Yuen Peng Tan, Wee Ling Chng, Steven Tucker, Lynette Su-Mien Ngo, George Wai Cheong Yip, Min En Nga, Susan Swee Shan Hue, Thomas Choudary Putti, Boon Huat Bay, Qingsong Lin, Lihan Zhou, Mikael Hartman, Tze Ping Loh, Manikandan Lakshmanan, Sook Yee Lee, Vinay Tergaonkar, Huiwen Chua, Adeline Voon Hui Lee, Eric Yew Meng Yeo, Mo-Huang Li, Chan Fong Chang, Z. Dynamic altruistic cooperation within breast tumors. Molecular cancer. 2023, 22 (1): 206Cited : 0Read More
- 48)- Philipp Knopf, Dimitri Stowbur, Sabrina H L Hoffmann, Natalie Hermann, Andreas Maurer, Valentina Bucher, Marilena Poxleitner, Bredi Tako, Dominik Sonanini, Balaji Krishnamachary, Sanhita Sinharay, Birgit Fehrenbacher, Irene Gonzalez-Menendez, Felix Reckmann, David Bomze, Lukas Flatz, Daniela Kramer, Martin Schaller, Stephan Forchhammer, Zaver M Bhujwalla, Leticia Quintanilla-Martinez, Klaus Schulze-Osthoff, Mark D Pagel, Marieke F Fransen, Martin Röcken, André F Martins, Bernd J Pichler, Kamran . Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors. Molecular cancer. 2023, 22 (1): 207Cited : 4Read More
- 49)- Penglei Wang, Kyle Laster, Xuechao Jia, Zigang Dong, Kangdong Liu. Targeting CRAF kinase in anti-cancer therapy: progress and opportunities. Molecular cancer. 2023, 22 (1): 208Cited : 1Read More
- 50)- Jie Zheng, Fengling Liu, Cheng Su. Unveiling the hidden AP-1: revealing the crucial role of AP-1 in ccRCC at single-cell resolution. Molecular cancer. 2023, 22 (1): 209Cited : 0Read More
